These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12673033)

  • 1. Brain and heart specific alteration of methamphetamine (MAP) distribution in MAP-sensitized rat.
    Nakagawa N; Hishinuma T; Nakamura H; Yamazaki T; Tsukamoto H; Hiratsuka M; Ido T; Mizugaki M; Terasaki T; Goto J
    Biol Pharm Bull; 2003 Apr; 26(4):506-9. PubMed ID: 12673033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of haloperidol and cocaine pretreatments on brain distribution and kinetics of [11C]methamphetamine in methamphetamine sensitized dog: application of PET to drug pharmacokinetic study.
    Nakamura H; Hishinuma T; Tomioka Y; Ishiwata S; Ido T; Iwata R; Funaki Y; Itoh M; Fujiwara T; Yanai K; Sato M; Numachi Y; Yoshida S; Mizugaki M
    Nucl Med Biol; 1997 Feb; 24(2):165-9. PubMed ID: 9190247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography study of the alterations in brain distribution of [11C]methamphetamine in methamphetamine-sensitized dog.
    Nakamura H; Hishinuma T; Tomioka Y; Ido T; Iwata R; Funaki Y; Itoh M; Fujiwara T; Yanai K; Sato M; Numachi Y; Yoshida S; Mizugaki M
    Ann N Y Acad Sci; 1996 Oct; 801():401-8. PubMed ID: 8959054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.
    Kitaichi K; Morishita Y; Doi Y; Ueyama J; Matsushima M; Zhao YL; Takagi K; Hasegawa T
    Eur J Pharmacol; 2003 Mar; 464(1):39-48. PubMed ID: 12600693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations in brain distribution of methamphetamine in methamphetamine-sensitized animals].
    Mizugaki M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):187-91. PubMed ID: 8962438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography (PET) study of the alterations in brain distribution of [11C]methamphetamine in methamphetamine sensitized dog.
    Mizugaki M; Nakamura H; Hishinuma T; Tomioka Y; Ishiwata S; Suzuki H; Ido T; Iwata R; Funaki Y; Itoh M
    Nucl Med Biol; 1995 Aug; 22(6):803-7. PubMed ID: 8535342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET) study of the alterations in brain pharmacokinetics of methamphetamine in methamphetamine sensitized animals].
    Nakamura H
    Yakugaku Zasshi; 2001 Aug; 121(8):585-91. PubMed ID: 11523119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Neurosci Lett; 2008 Apr; 435(2):113-9. PubMed ID: 18346852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in biodistribution of 11C-methamphetamine (MAP), 14C-MAP, and 123I-N-isopropyl-iodoamphetamine (IMP) in MAP- and cocaine-sensitized animals.
    Numachi Y; Yoshida S; Inosaka T; Sato M; Mizugaki M; Kimura K; Hishinuma T
    Ann N Y Acad Sci; 1992 Jun; 654():153-9. PubMed ID: 1632580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
    Ichikawa J
    Yakubutsu Seishin Kodo; 1988 Sep; 8(3):389-403. PubMed ID: 3250152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of drug biodistribution in the methamphetamine sensitized rat brain.
    Numachi Y; Yoshida S; Inosaka T; Sato M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():644A-645A. PubMed ID: 1498986
    [No Abstract]   [Full Text] [Related]  

  • 12. NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats.
    Bu Q; Lv L; Yan G; Deng P; Wang Y; Zhou J; Yang Y; Li Y; Cen X
    Neurotoxicology; 2013 May; 36():17-23. PubMed ID: 23462569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
    Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
    Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Proteomics; 2007 Apr; 7(7):1131-9. PubMed ID: 17351886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cholecystokinin mRNA expression in methamphetamine-induced behavioral sensitization.
    Fukamauchi F
    Neurochem Int; 1996 Apr; 28(4):391-4. PubMed ID: 8740446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine--an in vivo dialysis study in freely moving rats.
    Akimoto K; Hamamura T; Kazahaya Y; Akiyama K; Otsuki S
    Brain Res; 1990 Jan; 507(2):344-6. PubMed ID: 2337776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.